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Loss of interleukin (IL)-7 or the IL-7 receptor alpha (IL-7R𝗂, CD127) results in severe 
immunodefi  ciencies in mice and humans. To more precisely identify signals governing IL-7 
function in vivo, we have disrupted the IL-7R𝗂 Y449XXM motif in mice by knock-in muta-
genesis (IL-7R𝗂449F). Thymic precursors were reduced in number in IL-7R𝗂449F mice, but in 
marked contrast to IL-7R𝗂−/− knockout mice, thymocytes and peripheral T cells developed 
normally. Strikingly, Listeria infection revealed that CD4 and CD8 T cells had different 
requirements for IL-7R𝗂 signals. CD4 T cells failed to mount a primary response, but 
  despite normal CD8 primary responses, maintenance of CD8 memory was impaired in 
IL-7R𝗂449F mice. Furthermore, we show that Bcl-2 is IL-7R𝗂 Y449 independent and 
  insuffi  cient for IL-7–mediated maintenance of CD8 memory.
The cytokine IL-7 is essential for development 
of murine pro–B and pro–T cells (1, 2) and 
  nor  mal function and survival of peripheral T 
cells (3). Loss of IL-7 or either component of its 
hetero  dimeric receptor, IL-7Rα (CD127) or 
γ common chain (γc; CD132), results in severe 
combined immunodefi   ciency in mice (1, 2) 
and T cell immunodefi  ciency in humans (4). 
Furthermore, IL-7 and its signaling have been 
shown to be essential in homeostasis and func-
tion of peripheral T cells (3).
Upon pathogen exposure, antigen-specifi  c 
T cells undergo clonal expansion and diff  eren-
tiate into eff  ector cells to clear the infection. 
To maintain homeostasis within the peripheral 
T cell niche, the majority of these eff  ector cells 
die by apoptosis. However, 5–10% of pathogen-
specifi  c clones are retained long term as mem-
ory T cells to mount a more effi   cient response 
upon subsequent exposure. Memory T cells are 
believed to last up to 15 yr in humans as seen in 
smallpox immunization (5), but the mechanism 
by which this occurs is an open question. Evi-
dence suggests that signals from the γc cytokines 
IL-7 and IL-15 are critical in the maintenance 
of memory CD8 T cells: IL-15 providing sig-
nals to drive basal levels of proli  feration (6–8) 
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and IL-7 providing survival signals by main-
taining expression of Bcl-2 (9).
In situations of lymphopenia, such as after 
chemotherapy and in cases of viral infection, 
T cells respond by initiating a proliferative 
program to replenish host lymphoid cellularity 
(10–12). IL-7 is up-regulated in this situation, 
suggesting that increased availability of IL-7 
plays a major role in altered homeostatic con-
ditions (13). IL-7 signaling has been shown to 
have a role in homeostatic proliferation (HP) of 
both naive and memory T cells (9, 12, 14–16). 
Naive CD4 and CD8 T cells rely on both IL-7 
and TCR signaling for HP (9, 17, 18). In con-
trast, HP of memory phenotype CD8+CD44hi 
T cells is primarily cytokine driven, using 
IL-15 to drive HP, although supraphysiologi-
cal doses of IL-7 have been shown to be suffi   -
cient in the absence of IL-15 (15, 19, 20). 
The requirements for memory CD4 T cell HP 
are less clear and may require a synergy of 
both IL-7 and TCR signaling for effi   cient re-
sponses (14). Studies have shown that naive 
T cells   develop a memory-like phenotype 
during HP and have features of functional 
memory T cells (21), raising the question of 
whether molecular pathways involved in HP 620  IL-7Rα Y449 IN T CELL DEVELOPMENT AND FUNCTION | Osborne et al.
are   similar to those that generate classical memory T cells af-
ter infection.
The γc is constitutively expressed at low levels on lym-
phocytes, but IL-7Rα expression is restricted to specifi  c 
stages of diff  erentiation to mediate cellular responses (22–24). 
Within the T cell lineage, IL-7Rα is expressed in the early 
stages of development on CD4−CD8− double negative (DN) 
cells, consistent with IL-7 cytokine or receptor defi  ciencies re-
sulting in a thymic developmental block at these early stages 
and a paucity of thymocytes diff  erentiating into CD4+CD8+ 
double positive (DP), CD4, or CD8 single positive (SP) or 
peripheral T cells (1, 2). IL-7Rα expression is down-regu-
lated on CD4+CD8+ DP thymocytes, likely to prevent 
transduction of survival signals to clones that do not meet the 
requirements of positive selection (25). IL-7Rα expression is 
then resumed and maintained on surviving CD4+ and CD8+ 
SP thymocytes (24) and is involved in survival and func-
tional responses of mature T cells (3, 9). It is thought that the 
primary function of IL-7 signaling in the DN stages is to 
provide survival signals because ectopic expression of the 
antiapoptotic Bcl-2 protein in IL-7Rα−/− mice has been 
shown to rescue T cell development (26, 27). Indeed, Bcl-2 
expression closely correlates with IL-7Rα expression during 
thymic maturation.
IL-7Rα activation reportedly initiates at least two sepa-
rate signaling cascades, the Jak/STAT pathway and the 
  phospatidylinositol-3 (PI3) kinase/Akt pathway. Phosphory-
lation of tyrosine (Y) residues of the IL-7Rα and γc by their 
constitutively associated Jak kinases leads to recruitment of 
Src homology 2 domain eff  ectors such as STAT5 and PI3 
kinase (24). Each of these cascades is thought to separately 
regulate Bcl-2 family members to promote survival of acti-
vated cells and increase resistance to apoptosis (28, 29). The 
distal three of four IL-7Rα cytoplasmic tyrosines (Y390, 401, 
449, and 456) are conserved between mice and humans. 
Of these, Y449, nested in a YXXM motif, is necessary for 
STAT5 activation and regulation of PI3 kinase in B cells and 
human thymocytes and T cells (30–32). Thus, Y449 is a criti-
cal residue in initiation of signaling cascades leading to cell 
diff  erentiation, proliferation, and survival (24, 29, 31). Y401 
is nested in a conserved YXXL motif that is less widely dis-
tributed and is nonessential for thymocyte development and 
STAT5 activation (29). Y456 is in the least optimal setting 
because it is not in an acidic context and is less than four amino 
acids from the carboxyl terminus of the receptor.
The severe developmental defect in IL-7−/− and IL-7Rα−/− 
mice hampers further analysis of the role of this essential 
cytokine in T cell function. To this end, we have generated 
an IL-7Rα “knock-in” mouse in which the gene has a site-
specifi  c mutation of Y449 to phenylalanine (F) (IL-7Rα449F) 
to specifi   cally abrogate Y449XXM-derived signals. Like 
IL-7Rα−/− mice, lymphocyte development is disrupted at 
early stages but is substantially restored in IL-7Rα449F mice 
revealing a signifi  cant role for IL-7Rα Y449–independent 
events. This IL-7Rα Y449–independent increase in lympho-
cyte cellularity is recapitulated in the periphery, and IL-7Rα449F 
mice develop signifi  cantly larger pools of peripheral T cells 
than IL-7Rα−/− mice. Thus, this model enables investiga-
tion of the role of IL-7Rα signaling in an in vivo context. In 
addition, known signaling pathways can be separated into 
Y449 dependence and independence and functional out-
comes described in these terms. Analysis of IL-7Rα449F T 
cells revealed a critical role for Y449-mediated signaling in 
physiologically relevant processes such as HP, generation of 
a primary CD4 T cell immune response, and maintenance of 
antigen-specifi  c CD8 memory T cells. Remarkably, Bcl-2 
regulation is near normal in IL-7Rα449F mice, and we con-
clude that maintenance of Bcl-2 expression is not suffi   cient 
for survival of CD8 memory T cells as has been previously 
suggested (9). Our analysis provides genetic separation of 
IL-7–mediated CD8 memory cell maintenance from survival 
provided by Bcl-2.
RESULTS
Generation of IL-7R𝗂449F mice
To analyze the role of signaling eff   ectors downstream of 
IL-7Rα on in vivo T lymphocyte function, we used homolo-
gous recombination with a replacement vector to generate the 
IL-7Rα449F knock-in mice (Fig. 1 A; and Fig. S1 and Sup-
plemental Materials and methods available at http://www
.jem.org/cgi/content/org/jem.20061871/DC1). The targeted 
IL-7Rα locus retained the endogenous promoter and up-
stream exons; however, exons 6–8 were replaced with cDNA 
encoding the transmembrane and cytoplasmic domains, with 
disruption of the YXXM motif by the Y449F substitution 
(Fig. 1 A). The phosphorylated IL-7Rα YXXM motif has 
been shown to be the binding site for the Src homology 2 
  domain of PI3 kinase and activation of downstream path-
ways (30–32). The NeoR selection marker was deleted by 
Cre-  mediated recombination to eliminate potential promoter 
eff  ects. Initial analysis of mutant IL-7Rα protein   expression 
from thymocyte lysates indicated patterns comparable to WT 
thymocytes with mature polypeptides (90 kD) (Fig. 1 B). 
Most importantly, we determined that the Y449F knock-in 
mutation did not aff  ect surface expression of IL-7Rα on pe-
ripheral CD4 and CD8 T cells (Fig. 1 C). Furthermore, sig-
naling analysis of WT and IL-7Rα449F–cultured T cell blasts 
showed that TCR activation of the Erk and p38 MAPK path-
ways was unaff  ected, but that IL-7 activation of STAT5 requires 
IL-7Rα Y449 (Fig. 1 D). Interestingly, IL-7 by itself does not 
induce phosphorylation of Akt (Fig. 1 D) or S6 kinase (unpub-
lished data) in primary murine T cells at the time points tested.
Development of early hematopoietic lineages 
in IL-7R𝗂449F mice
To perform a comprehensive analysis of hematopoietic de-
velopment in IL-7Rα449F mice, we investigated the eff  ect of 
loss of IL-7Rα Y449 signaling during development of early 
hematopoietic lineages using fl  ow cytometry. We found the 
total number of bone marrow hematopoietic stem cells (HSCs) 
and derivatives were unaff  ected by the mutation (Fig. 2 A). 
Once again, we determined that the Y449F knock-in JEM VOL. 204, March 19, 2007  621
ARTICLE
mutation does not aff  ect surface expression of IL-7Rα on 
HSCs (Fig. 2 B). However, the earliest thymic T cell progeni-
tors were severely impaired in both IL-7Rα mutants as in-
dicated by a 20-fold decrease in the total number of early 
thymic progenitors (ETPs; characterized as Lin−CD3−CD4−
CD8−CD25−CD117+ [33]) in IL-7Rα449F and IL-7Rα−/− 
mice in comparison to WT (Fig. 2 C).
IL-7R𝗂449F thymocytes bypass a developmental block
Complete disruption of IL-7Rα results in decreased survival 
of early T lymphocyte progenitors causing a severe cyto-
penia that precludes detailed analysis of its role in peripheral 
T cells (1, 2, 26). In contrast, IL-7Rα449F mice showed only 
a fourfold decrease in thymic cellularity compared with WT 
despite the severe ETP defect (Fig. 3 A, right), suggesting a 
role for IL-7Rα Y449-independent signaling in thymocyte 
development. In agreement with this hypothesis, the distri-
bution of thymocyte subsets in IL-7Rα449F mice was indis-
tinguishable from WT (Fig. 3 A, left). To further examine 
thymocyte development, WT, IL-7Rα449F, and IL-7Rα−/− 
thymocytes were analyzed by expression of CD44 and CD25 
in the CD4−CD8− DN compartment using fl  ow cytometry. 
At all DN stages (DNI, CD4−CD8−CD44+CD25−; DNII, 
CD4−CD8−CD44+CD25+; DNIII, CD4−CD8−CD44−
CD25+; DNIV, CD4−CD8−CD44−CD25−), the defects in 
IL-7Rα449F were less severe than in IL-7Rα−/− mice (Fig. 
3 B, left). In addition, IL-7Rα449F mice had signifi  cantly 
higher numbers of DP thymocytes than IL-7Rα−/− mice 
(Fig. 3 A). This could be explained by the observation that 
IL-7Rα449F and WT mice showed similar production of 
DP thymocytes from DNIV precursors,whereas IL-7Rα−/− 
DNIV cells encountered a severe developmental block at 
this stage (Fig. 3 B, right). This indicates an IL-7Rα Y449–
  independent compensatory mechanism that contributes to 
restoration of normal thymocyte development and partial 
rescue of total T cell numbers. The role of IL-7Rα signal-
ing in positive selection was examined by determining the 
Figure 1.  Generation of IL-7R𝗂449F knock-in mouse. (A) A targeting 
vector carrying a partial cDNA of the IL-7Rα transmembrane and cyto-
plasmic domains with Y449F site-specifi  c mutation (*) were used for 
  homologous recombination in ES cells. WT, targeted, fl  oxed and targeted 
(IL-7Rα449F) loci are shown (not to scale). Light gray boxes, exons; numerals 
below thick black lines, exon numbers; dark gray box, IL-7Rα cDNA. 
Sequences for neomycin (NEO) and thymidine kinase (TK) are shown. H, HindIII; 
B, BamHI; St, StuI; Bg, BglII; N, NotI, H*, HindIII site introduced. Probe 1 is a 
0.65-kb EcoRI-BamHI fragment upstream of the short arm (Supplemental 
Materials and methods). Probe 2 is a 202-bp fragment amplifi  ed from exon 
8, and the Neo probe is a 1.6-kb HindIII-SpeI fragment from the targeting 
vector. (B) Expression of IL-7Rα is maintained in IL-7Rα449F thymocytes. 
Thymocyte lysates were prepared from WT, IL-7Rα449F, and IL-7Rα−/− mice, 
and analyzed by immunoblot. Protein loading is indicated by the antitubulin 
immunoblot (bottom). (C) Site-specifi  c mutation of IL-7Rα Y449 does not 
affect expression of IL-7Rα on peripheral CD4 and CD8 T cells as assessed 
by fl  ow cytometry. Experiment is representative of three mice for WT, 
IL-7Rα−/−, and IL-7Rα449F in two independent experiments. Isotype anti-
body, dashed trace; anti–IL-7Rα, solid trace. (D) IL-7Rα Y449F mutation 
abrogates activation of STAT5, but identifi  es activation of the p38 MAPK 
pathway as Y449 independent. Neither Akt nor Erk are activated by IL-7 in 
T cells, but are effi  ciently activated by α-CD3 and IL-2 stimulation.622  IL-7Rα Y449 IN T CELL DEVELOPMENT AND FUNCTION | Osborne et al.
frequency of TCR-β+ DP thymocytes that had downregu-
lated heat stable antigen (HSA) (Fig. 3 C) or upregulated the 
maturation marker CD69 (unpublished data). These analyses 
showed that neither complete deletion nor mutation of 
IL-7Rα resulted in impaired positive selection, and we con-
clude that IL-7Rα is nonessential in this process.
Commitment to the γδ T cell lineage is IL-7Rα depen-
dent (34) and occurs late in the DNII to DNIII stage (35). We 
assessed γδ development by fl  ow cytometry by staining total 
thymocytes with anti-γδ antibody and a lineage cocktail. 
Our data showed that γδ development is Y449 dependent 
because their numbers were markedly diminished (Fig. 3 D). 
Collectively, our data shows that IL-7Rα Y449 signals play 
critical roles in both αβ and γδ T cell development.
To examine the basis of restored cellularity in IL-7Rα449F 
mice, cell turnover was determined by BrdU incorporation 
to monitor uptake by rapidly cycling DN thymocytes. We 
found IL-7Rα449F DNIV cells that lack surface expression of 
the mutated IL-7Rα (unpublished data) have markedly de-
creased BrdU uptake, whereas the DNIII and DP stages un-
dergo more rapid cycling compared with WT (Fig. 3 E). 
Collectively, the data suggest that IL-7Rα–driven cell divi-
sion in DN and DP thymocytes is Y449 independent.
To examine the severity of the IL-7Rα449F mutation on 
developmental potential, competitive repopulation experi-
ments were performed. This analysis revealed that IL-7Rα449F 
thymocytes were less robust than their WT counterparts. 
Similar to what was seen in whole mice, when either WT or 
IL-7Rα449F whole bone marrow were delivered separately, 
IL-7Rα449F recipient thymic development resulted in four-
fold lower cellularity than WT recipients (unpublished data). 
However, when WT (CD90.1+) and IL-7Rα449F (CD90.2+) 
whole bone marrow were delivered at a 1:1 ratio, the thymic 
output was comprised of <5% IL-7Rα449F–derived cells, al-
though subset distribution was still normal (Fig. 3 F). Collec-
tively, our data shows that knock-in disruption of IL-7Rα 
Y449 signals causes stage-specifi  c defects, particularly dra-
matic at the ETP stage, but that these are bypassed to gener-
ate normal thymocyte subsets.
IL-7R𝗂 Y449-independent signals are involved in peripheral 
T cell development
The severe developmental defect in IL-7Rα−/− thymocytes 
(1) causes a paucity of T cells in the periphery that confounds 
further analysis of the role of IL-7 in T cell function (3). 
When peripheral T cells were examined in IL-7Rα449F mice, 
we found that the relative subset distribution is similar be-
tween IL-7Rα449F and WT mice, whereas IL-7Rα−/− mice 
had a severe disruption of CD4 and CD8 T cell development 
(Fig. 4 A). Quantifi  cation of peripheral lymphocytes revealed 
that IL-7Rα449F mice had signifi  cantly lower total cell num-
bers than WT mice (CD4 T cells: 2.5 ± 0.3; CD8 T cells: 
3.8 ± 0.6; B cells: 3.7± 1.0 fold decrease, n = 3) but that 
these subsets were higher than in IL-7Rα−/− mice, thus in-
dicating that lymphocyte development is partially IL-7Rα 
Y449 independent (Fig. 4 B). Consistent with the expectation 
that this targeted mutation only aff  ects  IL-7Rα–mediated 
events, development of NK cells (NK1.1+CD3−) was unaf-
fected in the spleens of both IL-7Rα449F and IL-7Rα−/− 
mice (Fig. 4 B). TCR-β and CD3ε expression levels on WT, 
IL-7Rα449F, and IL-7Rα−/− splenic T cells were analyzed by 
fl  ow cytometry and found to be comparable between WT 
and IL-7Rα449F mice, whereas those from IL-7Rα−/− mice 
were severely defi  cient (Fig. 4 C). This shows that IL-7Rα 
Y449 signaling is dispensable for peripheral T cell maturation 
as assessed by antigen receptor expression.
To eliminate the possibility of altered expression of other 
γc receptor family members in IL-7Rα449F mice accounting 
for diff  erences in peripheral T cell function, surface expres-
sion levels of cytokine receptor chains γc and IL-2/15Rβ 
were examined. Our data showed only marginal dif-
ferences in IL-7Rα and γc expression between WT and 
IL-7Rα449F CD4 and CD8 T cells, although the frequency of 
IL-2/15Rβ–expressing cells was increased in both IL-7Rα449F 
and IL-7Rα−/− T cells (Fig. S2, available at http://www
.jem.org/cgi/content/org/jem.20061871/DC1).
Homeostatic proliferation is IL-7R𝗂 Y449 dependent
Because IL-7Rα449F mice are able to support T cell develop-
ment, we sought to address what aspects of T cell function 
were impaired or retained. IL-7 has been shown to be involved 
Figure 2.  Bone marrow progenitor populations and IL-7R𝗂 
  expression are normal in IL-7R𝗂449F mice. (A) Bone marrow progenitors 
develop at similar frequencies (left) and total cell numbers (right) in mice 
with targeted IL-7Rα449F mutation. Bar graphs are gated on Lin−Sca1+c-kit+ 
HSCs and their Lin−Sca1loc-kit+ derivatives (post-HSCs). (B) IL-7Rα is 
expressed normally on IL-7Rα449F bone marrow populations as determined 
by FACS analysis. Isotype antibody, dashed trace; anti–IL-7Rα, solid trace. 
(C) The frequency of ETPs is decreased in both IL-7Rα−/− and IL-7Rα449F thymi 
compared with WT. FACS plots shown are gated on Lin−CD44+CD25− DNI 
populations. WT, black bars; IL-7Rα−/−, unfi  lled bars; IL-7Rα449F, hatched 
bars. All experiments are representative of at least three mice for WT, 
IL-7Rα−/−, and IL-7Rα449F in two independent experiments.JEM VOL. 204, March 19, 2007  623
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Figure 3.  An early thymocyte defect is bypassed in IL-7R𝗂449F 
mice. (A) FACS analysis shows that IL-7Rα449F thymocytes develop DN, 
DP, CD4 SP, and CD8 SP populations in frequencies similar to WT mice 
(left). Total cellularity in IL-7Rα449F mice is reduced in comparison to WT 
but signifi  cantly higher than in IL-7Rα−/− littermates (right). (B) DN thy-
mocyte development is affected by IL-7Rα449F mutation (left). Mean cell 
numbers are shown in quadrants. The transition to DP thymocytes is 
unaffected in IL-7Rα449F mice (right). (C) Positive selection is IL-7Rα inde-
pendent as shown by frequency of TCR-β+ HSAlo cells in WT, IL-7Rα−/−, 
and IL-7Rα449F DP thymocytes. (D) γδ T cell development is impaired in 
the absence of IL-7Rα Y449 signaling. Bar charts show the number of 
anti-γδ TCR+ lymphocytes in the thymus. (A, B, and D) WT, black bars; 
IL-7Rα−/−, unfilled bars; IL-7Rα449F, hatched bars. (E) BrdU uptake 
  revealed cell cycling is increased in DNIII and DP stages but decreased in 
DNIV IL-7Rα449F thymocytes. Isotype antibody, dashed trace; anti-BrdU, 
solid trace. (F) Competitive repopulation shows IL-7Rα449F– derived cells 
were able to differentiate normally but are poorly competitive. Bar chart 
(left) and contour plots (right) are gated on CD90.1+ CD45.2+ (black bar) 
and CD90.1− CD45.2+ (hatched bar) thymocytes. Numbers in bar charts 
represent the mean thymocyte recovery from each genotype. All experi-
ments are representative of at least three mice for WT and IL-7Rα449F. 
IL-7Rα−/− samples were pooled from three to six mice.624  IL-7Rα Y449 IN T CELL DEVELOPMENT AND FUNCTION | Osborne et al.
in homeostatic proliferation of naive CD4 and CD8 T cells 
(9, 13, 14). To address the role of IL-7Rα Y449 in homeo-
static proliferation, IL-7Rα449F and WT (CD45.2+) T cells were 
labeled with the mitotic tracker CFSE and transferred into 
  either normal or irradiated recipient host mice (CD45.1+). In 
stark contrast to WT T cells, IL-7Rα449F T cells were unable 
to proliferate when transferred into acutely lymphopenic 
hosts as measured by CFSE dilution (Fig. 5). Indeed the defi  -
ciency was as severe as that in IL-7Rα−/− cells. A small pool 
of CD8 T cells undergo limited rounds of division, but these 
appear IL-7Rα independent because it was also observed 
with IL-7Rα−/− cells (Fig. 5). Our data strongly argue that 
homeostatic proliferation of both CD4 and CD8 T cells is 
dependent on signals initiated by IL-7Rα Y449.
IL-7R𝗂 Y449 is essential for CD4 primary immune responses
To determine the role of IL-7Rα Y449 in generating a func-
tional polyclonal T cell immune response in vivo, WT and 
IL-7Rα449F mice were infected with a recombinant Listeria 
monocytogenes strain expressing an immunodominant foreign, 
MHC class I (Kb)–restricted peptide, SIYRYYGL (rLM-SIY) 
(Priatel, J., L. Zenewicz, H. Shen, and H. Teh, personal com-
munication). Primary responses to rLM-SIY were monitored 
at day 7, and antigen-specifi  c T cells were enumerated by 
IFN-γ production in CD4 or CD8 T cells after in vitro stimu-
lation with immunodominant MHC class II (listeriolysin O 
[LLO]190-201)– and MHC class I (SIY)–restricted peptides, 
  respectively. Surprisingly, IL-7Rα449F CD4 T cells failed to 
generate a detectable primary immune response after infec-
tion (Fig. 6 A). In contrast, IL-7Rα449F CD8 T cells mounted 
a robust response that was equivalent to WT controls in total 
cell numbers (Fig. 6 A), independent of lower initial T cell 
numbers in IL-7Rα449F mice. In vitro anti-CD3/anti-CD28 
TCR stimulation assays showed that IL-7Rα449F CD4 and 
CD8 T cells had impaired proliferation response to low, but 
not high, levels of TCR stimulation (Fig. 6 B) and this may 
account for the defective CD4 primary response.
To determine whether or not the decrease in B cells or an 
altered splenic compartment could account for the lack of CD4 
T cell primary response in IL-7Rα449F mice, equal numbers of 
WT Thy1.1 (CD90.1+) T cells were adoptively transferred into 
WT and IL-7Rα449F CD90.2+ hosts. The mice were infected 
with rLM-SIY and responses measured at day 7 after infection 
by determining IFN-γ expression upon in vitro stimulation 
with the indicated peptides. The fact that WT CD90.1+ CD4 
T cells responded strongly in IL-7Rα449F hosts (Fig. 6 C) con-
fi  rmed that the IL-7Rα449F CD4 defect was T cell intrinsic and 
not a result of ineffi   cient antigen presentation. These data show 
that CD4, but not CD8 T cells, require IL-7Rα Y449– mediated 
signals to generate primary responses to rLM-SIY.
IL-7R𝗂 Y449 is essential for maintenance 
of CD8 T cell memory
Previous reports have suggested that IL-7Rα is critical for the 
generation and/or maintenance of T cell memory. The fact 
Figure 4.  Disruption of IL-7R𝗂 Y449 signaling only partially per-
turbs peripheral lymphocyte development. (A) Peripheral CD4 and CD8 
T cells develop in IL-7Rα449F mice and confi  rm involvement of IL-7Rα 
Y449–independent pathways. (B) Quantifi  cation of FACS data shows that 
peripheral T and B cell development is reduced in IL-7Rα449F compared 
with WT but signifi  cantly higher than in IL-7Rα−/− littermates and sup-
ports a role for IL-7Rα Y449–independent signaling requirements. Natural 
killer cells (CD3−NK1.1+) are unaffected by abrogation of IL-7Rα Y449 
signals. Data is expressed as the percentage of WT cellularity, IL-7Rα−/− 
(white bars), and IL-7Rα449F (hatched bars). (C) IL-7Rα Y449–independent 
signaling allows for accumulation of mature CD3+TCRβ+ T cells in the 
periphery. See Fig. S2.
Figure 5.  Signals from IL-7R𝗂 Y449 are essential for IL-7–driven 
homeostatic proliferation. Experiments are representative of two to 
four recipient mice from WT, IL-7Rα449F, and IL-7Rα−/− T cells in two 
  independent experiments. Irradiated hosts, black, fi  lled trace; nonirradiated 
hosts, white trace.JEM VOL. 204, March 19, 2007  625
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that IL-7Rα449F mice mount a strong primary CD8 T cell re-
sponse to the MHC class I–restricted SIY peptide enabled us 
to investigate whether the formation of CD8 T cell mem-
ory is dependent on IL-7Rα Y449. WT and IL-7Rα449F 
mice were infected with rLM-SIY and analyzed 45 d later for 
antigen-specifi  c memory CD8 T cells by expression of IFN-γ 
in response to peptide. Despite generating equivalent numbers 
of CD8 T cell eff  ectors as WT at day 7, IL-7Rα449F mice 
showed an eightfold reduction in memory CD8 T cell numbers 
compared with WT mice (Fig. 7 A). Not surprisingly, the 
severely impaired primary CD4 T cell response in IL-7Rα449F 
mice resulted in very few LLO-reactive memory CD4 T cells. 
This experiment indicates an essential role for IL-7Rα Y449 
signaling in regulation of CD8 memory T cells.
To test the fi  tness of IL-7Rα449F memory T cells, WT 
and IL-7Rα449F mice previously immunized with rLM-SIY 
were homologously rechallenged at 100 d after infection. 3 d 
after reinfection, the IL-7Rα449F mice showed an increase in 
the number of SIY-specifi  c CD8 T cells but failed to reach 
the same level as achieved by WT controls (Fig. 7 B).
Because IL-7Rα449F T cells have impaired proliferation at 
low dose stimulus of the TCR, the possibility existed that the 
number of IL-7Rα449F memory CD8 T cells was underesti-
mated by assessing their ability to produce IFN-γ upon pep-
tide challenge. To confi  rm our fi  ndings of decreased CD8 
memory T cells, an H2-Kb MHC I–Ig fusion protein conju-
gated to PE (MHC–Ig dimer) was loaded with SIY peptide 
and used for detection of antigen-specifi  c cells. As shown in 
Fig. 7 C, the number of IL-7Rα449F memory CD8 T cells 
remains signifi  cantly lower (2.5-fold) than WT at day 60, 
  although the decrease is not quite as dramatic as that shown 
by IFN-γ induction. This suggests that antigen-specifi  c 
IL-7Rα449F memory CD8 T cells have compromised TCR-
  mediated cytokine induction. Strikingly, when memory T 
cells were assayed at day 100 in a parallel experiment, the WT 
CD8 memory T cell numbers remained constant, whereas 
IL-7Rα449F CD8 memory T cell numbers continued to decrease 
(Fig. 7 C). These data demonstrate a requirement for IL-7Rα 
Y449 signals in maintenance and long term survival of mem-
ory CD8 T cells.
To address whether or not the lack of a primary CD4 T 
helper cell expansion in the IL-7Rα449F mice was aff  ecting 
the generation of an effi   cient memory CD8 T cell compart-
ment, we performed adoptive transfer experiments wherein 
WT CD90.1+ T cells were transferred into IL-7Rα449F 
(CD90.2+) hosts. This allows WT and IL-7Rα449F CD8 T cells 
to encounter antigen in the same environment and receive 
the same signals from activated WT CD4 T helper cells. 
WT and IL-7Rα449F antigen-specifi  c CD8 T cells were enu-
merated using MHC–Ig dimer staining at day 7 and 45 after 
rLM-SIY infection. To account for diff  erences in transplant 
versus host cell numbers within spleens, we normalized the 
number of antigen-specifi  c CD8 memory T cells against the 
number of antigen-specifi  c primary CD8 T cells and repre-
sented this as a percentage. The normal range of eff  ector 
T cells that survive the contraction period to become mem-
ory cells is between 5 and 10%. We saw that >15% of WT 
but <5% of IL-7Rα449F eff  ector CD8 T cells were main-
tained at memory stage at day 45 after infection (Fig. 7 D), 
refuting the hypothesis that lack of CD4 T cell help accounts 
for the defect in IL-7Rα449F CD8 T cell memory.
Figure 6.  IL-7R𝗂 Y449 is essential for the CD4 primary response 
to L. monocytogenes. (A) CD4 but not CD8 T cells require IL-7Rα Y449 
for differentiation into effector cells. Bar charts represent total cell 
  numbers of CD4+ IFN-γ+ or CD8+ IFN-γ+ T cells from WT (black bars) or 
IL-7Rα449F (hatched bars) spleens at day 7 after infection. (B) Decreased 
TCR proliferation in IL-7Rα449F CD4 and CD8 T cells at low concentrations 
of agonist stimulation. The doses of plate-bound α-CD3 are indicated. 
Histograms show representative results of one to three replicates. WT, 
solid trace; IL-7Rα449F, dashed trace. (C) Adoptively transferred WT Thy1.1 
(CD90.1+) CD4 and CD8 T cells respond to rLM-SIY infection equally well 
in WT (CD90.1−) and IL-7Rα449F (CD90.1−) hosts. Bar charts represent 
the number of Thy1.1 antigen–specifi  c T cells recovered from WT hosts 
(black bars) and IL-7Rα449F hosts (hatched bars). Data are representative 
of at least three infected mice of each genotype for each experiment.626  IL-7Rα Y449 IN T CELL DEVELOPMENT AND FUNCTION | Osborne et al.
We therefore looked at possible cell intrinsic disruptions 
in IL-7Rα449F CD8 memory T cells. Memory T cells re-
quire a balance of cell survival and low-level proliferation for 
long-term maintenance. Previous studies have demonstrated 
a role for IL-7 in survival of memory CD8 T cells by regu-
lating levels of the survival factor Bcl-2 (9, 36). Using intra-
cellular staining and fl  ow cytometry, we found that the levels 
of Bcl-2 in WT and IL-7Rα449F CD8+ IFN-γ+ memory T 
cells were equivalent after rechallenge (Fig. 7 E) and at day 
45 after infection (not depicted), and therefore cannot ac-
count for the maintenance defect. IL-15 has been demon-
strated to regulate proliferation of memory CD8 T cells 
(6–8), but it remained possible that the IL-7Rα449F memory 
CD8 T cell pool was decreasing over time because of de-
creased proliferation. In agreement with previous studies 
that cycling of memory cells is regulated by IL-15 (37), we 
found that the cycling of IL-7Rα449F memory CD8 T cells 
was not disrupted as shown by BrdU incorporation (Fig. 
7 F). Thus, the defect in IL-7Rα449F memory CD8 T cells 
does not result from impaired cycling or from a lack of Bcl-2 
survival signals.
STAT5, but not Bcl-2, is IL-7R𝗂 Y449 dependent
To more fully address the requirement of IL-7Rα Y449 in 
activation of known IL-7 signaling pathways, WT and 
IL-7Rα449F thymocytes and splenocytes were stimulated ex 
vivo with purifi  ed, recombinant IL-7 and analyzed by fl  ow 
cytometry for phosphorylation of STAT5 and up-regulation 
of Bcl-2. This analysis showed that STAT5 activation was 
entirely IL-7Rα Y449 dependent in all IL-7–responsive sub-
sets (thymic DN, CD4 and CD8, and splenic CD4 and CD8 
T cells) (Fig. 8 A). Surprisingly, two prosurvival members of 
the Bcl-2 family, Bcl-2 and Bcl-xL, were IL-7Rα Y449 in-
dependent (Fig. 8 B and unpublished data). Analysis of Bcl-2 
regulation showed that IL-7Rα449F DN thymocytes had de-
creased levels of Bcl-2 after 24 h ex vivo culture compared 
with WT and that they were severely impaired in their ability 
to up-regulate Bcl-2 in response to IL-7 (Fig. 8 B). However, 
the remaining thymocyte subsets and peripheral T cells 
showed signifi  cant induction of Bcl-2 expression at the same 
time points (Fig. 8 B) leading to the conclusion that IL-7–
mediated Bcl-2 regulation is mostly Y449 independent. Our 
fi  ndings support the hypothesis that IL-7–induced Bcl-2 is 
important during the DN stages of development to impart 
survival signals that allow diff   erentiation events to occur 
(26, 27), but importantly, refutes the notion that Bcl-2 is 
 suffi   cient in IL-7Rα–mediated events in peripheral T cells, 
particularly maintenance of CD8 memory T cells.
DISCUSSION
Existing knockout models have severe limitations for dis-
cerning the requirement of IL-7Rα–induced signaling path-
ways downstream of T cell function in the periphery caused 
by secondary eff  ects (1, 3, 38, 39). We have established a 
novel model, the IL-7Rα449F knock-in mouse, which allows 
analysis of development and function in T and B cells in the 
Figure 7.  CD8 memory T cells require signals from IL-7R𝗂 Y449 
for long-term maintenance. (A) IL-7Rα449F CD8 T cells are defective in 
their ability to survive and generate a stable pool of antigen-specifi  c 
memory cells. (B) Rechallenge with rLM-SIY at day 100 showed that 
recovery of antigen-specific CD8 memory T cells was significantly 
impaired in IL-7Rα449F mice. (C) Analysis of SIY-specifi  c T cells at days 
60 and 100 after rLM-SIY infection using SIY-loaded MHC–Ig dimer 
showed that IL-7Rα449F memory CD8 T cells numbers are impaired and 
decrease over time. Data shown is representative of four mice of each 
genotype. (D) Adoptive transfer of WT CD90.1+ CD4 and CD8 T cells 
allows generation of WT CD8 memory, but provision of WT CD4 T cell 
help is insuffi  cient for IL-7Rα449F CD8 T cell memory. % of primary 
  effectors persisting as memory = no. of d45 CD8+ Dimer+ / no. of d7 
CD8+Dimer+ × 100. Data shown is based on four transplanted mice 
at each time point. (E) Intracellular Bcl-2 was measured in peptide-
stimulated CD8+IFN-γ+ T cells of WT and IL-7Rα449F mice at memory 
stages. No signifi  cant difference was detected in frequency of Bcl-2+ 
cells. Isotype antibody, gray fi  lled trace; unstimulated, dashed trace; SIY 
stimulated, solid trace. Data shown is representative of three mice of 
each genotype and two independent experiments. (F) BrdU incorpora-
tion is similar in WT and IL-7Rα449F memory CD8 T cells at day 45 after 
rLM-SIY infection. Histograms are gated on CD8+IFN-γ+ cells. Solid 
trace, WT; dashed trace, IL-7Rα449F. Data is representative of three WT 
and IL-7Rα449F mice.JEM VOL. 204, March 19, 2007  627
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absence of IL-7Rα signaling from the Y449 residue. IL-7Rα 
Y449 was chosen for site-directed mutagenesis because pre-
vious work had linked activation of the PI3 kinase in B cells 
(30), human thymocytes (31), a human T lymphoblastoid cell 
line (32), and more recently, the STAT5 pathway to this resi-
due (29). Similar to what is seen in IL-7Rα−/− mice, our 
analysis reveals that Y449 signaling is important in the early 
stages of T cell development. However, unlike IL-7Rα−/− 
mice, there is partial rescue of T cell numbers at later stages 
of thymic development. This novel aspect of the IL-7Rα449F 
mouse model means that in contrast with IL-7Rα−/− mice, 
IL-7Rα449F peripheral T cells are present at numbers amena-
ble to further analysis.
The defect seen in the number of ETPs detected in 
IL-7Rα449F relative to that of WT suggests a role for IL-7Rα 
signaling at the earliest stages of T cell development. This is 
seen despite the lack of IL-7Rα on the surface of ETPs (40) 
and is thus suggestive of either defective traffi   cking of pro-
genitors into the thymus or a survival defect in the circulating 
Lin−sca1+c-kit+ progenitor. Although a small population of 
circulating Lin−c-kit−B220+CD19−CD44hi cells has been 
reported to have T cell precursor potential (41), this elusive 
population (42) has not been quantifi  ed in the IL-7Rα449F 
mouse. Because the bone marrow HSC and post-HSC com-
partments are normal in both IL-7Rα449F and IL-7Rα−/− 
animals, it is likely that the IL-7Rα449F mutation aff  ects 
early diff  erentiation or survival events that account for the 
decrease in resident thymic progenitors. The diff  erence in ETP 
develop  ment between IL-7Rα449F and IL-7Rα−/− also indi-
cates signaling events that occur independently of the Y449 
residue are suffi     cient to support some ETP development. 
Moreover, Y449-independent signals are suffi   cient to enable 
further T cell development because the 20-fold decrease in 
ETPs is overcome and thymocyte and peripheral T cell num-
bers are decreased by only fourfold. Our data also suggests 
that positive selection occurs in the absence of IL-7Rα–
  dependent signals because cells that successfully transition 
from DNIV to DP have normal frequencies of cells down-
regulating HSA and upregulating CD69. Together with our 
data showing IL-7Rα Y449–dependent Bcl-2 up-regulation 
in the DN compartment, these fi  ndings strongly support the 
hypothesis that the primary role of IL-7Rα in early thymo-
cyte development is providing Bcl-2–mediated protection 
from apoptosis. Although the IL-7Rα subunit is also shared 
with the thymic stromal lymphopoietin (TSLP) receptor to 
mediate TSLP signaling (43), it does not appear that the ef-
fects of IL-7Rα449F disruption are TSLP mediated because 
TSLP and TSLP receptor knockouts show no major B or 
T cell development defects (44, 45).
The limited defects we found in the IL-7Rα449F mice en-
abled us to expand on the role of IL-7Rα in the development 
and function of peripheral T cells as established by the 
IL-7−/− and IL-7Rα−/− mouse models and other indirect 
methods of blocking IL-7Rα function. For example, studies 
using adoptive transfer systems and/or neutralizing antibodies 
to IL-7Rα have shown that IL-7 plays a role in HP of naive 
Figure 8.  IL-7R𝗂449F mutation abrogates activation of STAT5 but 
Bcl-2 up-regulation is Y449 independent. (A) Intracellular fl  ow cyto-
metry of WT and IL-7Rα449F lymphocytes stimulated ex vivo showed that 
activation of the STAT5 pathway is dependent on IL-7Rα Y449 in both the 
thymus and periphery. Isotype antibody, gray fi  lled trace; untreated, dashed 
trace; +IL-7, solid trace. (B) Bcl-2 up-regulation is IL-7Rα Y449 independ-
ent in all thymic subsets and peripheral T cells except DN. Bar charts shown 
represent WT −IL-7, unfi  lled bars; WT +IL-7, black bars; IL-7Rα449F –IL-7, 
gray bars; IL-7Rα449F +IL-7, hatched bars. All experiments are representative 
of at least three mice for each genotype and two independent experiments.628  IL-7Rα Y449 IN T CELL DEVELOPMENT AND FUNCTION | Osborne et al.
T cells (9, 17) and is essential for survival of memory CD4 
(14) and CD8 (9) T cells. Previous studies have indicated that 
the transcription factor STAT5 is involved in HP (46, 47). 
Our study supports these fi  ndings and provides a direct link 
between IL-7Rα Y449–mediated STAT5 activation and ef-
fi  cient homeostatic proliferation. The pool of proliferating 
IL-7Rα449F CD8 T cells are IL-7Rα independent and are 
likely memory phenotype cells responding to IL-15 signaling. 
Interestingly, IL-7Rα449F T cells have attenuated responses to 
low dose α-CD3 and anti-CD28 stimulation, suggesting pos-
sible integration of TCR and IL-7Rα downstream signaling. 
The decreased proliferation elicited by low levels of TCR 
signaling may contribute to impaired HP since previous work 
has suggested that IL-7 and TCR signaling synergize to pro-
mote optimal HP (17).
Most importantly, our data is at odds with the hypothesis 
that regulation of Bcl-2 is suffi   cient for maintenance of mem-
ory CD8 T cells. Previously, an adoptive transfer experiment 
of IL-7Rα−/− OT-I transgenic TCR CD8 T cells concluded 
that the defect in maintenance of memory CD8 T cells in this 
system was the decreased level of prosurvival Bcl-2 in these 
cells (9). However, IL-7Rα449F CD8 memory T cells express 
normal levels of Bcl-2 yet do not demonstrate long-term 
maintenance. Expression of Bcl-2 is not caused by antigen 
stimulus because the same frequency of unstimulated controls 
express similar levels of Bcl-2. These data indicate two pos-
sible mechanisms to explain the defect of IL-7Rα449F CD8 
memory T cells: fewer T cells from the primary response could 
be recruited to memory during the immune contraction 
phase, or if contraction is normal, the memory cells could 
be lacking a survival signal other than Bcl-2, such as Bcl-xL 
or Mcl-1.
Although the original pool of eff  ector CD8 T cells is the 
same size as WT controls, by day 45 the IL-7Rα449F pool of 
CD8 memory T cells is signifi  cantly smaller and continues to 
decrease over time. These cells retain the ability to expand 
upon secondary challenge in vivo, indicating that although 
CD4 T cells do not generate a primary response their pres-
ence is suffi   cient to provide the “help” signals necessary for 
reexpansion. This is further supported by our data showing 
that even in the presence of WT CD4 T cells, a smaller pro-
portion of IL-7Rα449F eff  ector CD8 T cells are maintained to 
memory stage than WT cells generated in the same host. 
  Finally, this is in agreement with the fi  nding that CD4 help 
after acute infection is antigen independent (48). Nonethe-
less, the decrease in cell numbers or the absence of IL-7Rα 
Y449–dependent signals compromises functional effi   cacy of 
CD8 memory T cells. When IL-7Rα449F mice were chal-
lenged with a homologous prime/boost regimen with a more 
virulent  L. monocytogenes expressing gp33 of lymphocytic 
choriomeningitis virus, IL-7Rα449F CD8 memory T cells were 
unable to provide protective immunity (unpublished data).
Our in vivo analyses extend upon a report describing the 
eff  ect of IL-7Rα Y449F mutation (29). In agreement with 
our fi  ndings in primary cells, that study showed that activa-
tion of STAT5 is Y449 dependent. However, in contrast to 
the suggestion that IL-7–mediated Bcl-2 regulation is also 
Y449 dependent, our in vivo model shows that loss of Bcl-2 
up-regulation is dramatic in DN thymocytes but is mostly 
restored at later stages of development in the IL-7Rα449F 
mouse. Moreover, we have found that IL-7 does not induce 
PI3 kinase activation in murine primary T cells as measured by 
Akt phosphorylation. This is in contrast to B cells and human 
T cells (for review see reference 49) but is in keeping with 
fi  ndings in the CT6 murine T cell line (50). Our data suggests 
that IL-7 induction of Bcl-2 is STAT5 and Akt independent.
In conclusion, we have characterized a novel IL-7Rα 
mutant mouse that has provided insight into the role of IL-7 
signaling during early stages of T cell development and func-
tion of peripheral T cells. We show that IL-7Rα Y449–
dependent signals such as STAT5 are required for accu  mulation 
of ETPs in the thymus. Interestingly, we also demonstrate a 
functional defect in the ability of IL-7Rα449F CD4 T cells 
to generate a primary response to infection with rLM-SIY. 
This suggests a previously underappreciated role for IL-7 sig-
naling in either TCR repertoire selection or for acquiring 
eff  ector function. In contrast, IL-7Rα449F CD8 T cells un-
dergo vigorous expansion at acute stages of infection, but a 
defect becomes apparent in the maintenance of these cells 
to memory stage. The loss of antigen-specifi  c CD8 memory 
T cells despite continued Bcl-2 expression disputes a suffi   -
cient role for Bcl-2 in IL-7–mediated events in peripheral 
T cells (9). This suggests that IL-7–induced survival of CD8 
memory T cells requires more than Bcl-2 expression and is 
being investigated further.
MATERIALS AND METHODS
Mice. Animals were housed at the University of British Columbia, Microbi-
ology and Immunology Department Animal Facility in accordance with Uni-
versity of British Columbia Animal Care and Biosafety Committee certifi  cates. 
C57BL/6, B6.SJL-Ptprca Pepcb (BoyJ), B6.PL-Thy1a/CyJ (Thy1.1+), and 
IL-7Rα−/− mice were obtained from The Jackson Laboratory.
IL-7R𝗂449F mice generation. IL-7Rα449F mice were generated by ho-
mologous recombination as detailed in Supplemental Materials and methods 
(available at http://www.jem.org/cgi/content/org/jem.20061871/DC1). 
A replacement vector was generated in pKSloxPNT (51) (provided by 
  Robert Farese, Gladstone Institute of Cardiovascular Disease, University of 
California, San Francisco, CA) that substituted exons 6–8 encoding the 
transmembrane and cytoplasmic domains of IL-7Rα with a partial cDNA 
(nucleotides 707–1,398) encoding a Y-to-F mutation at residue 449 and an 
SV40 polyadenylation signal. The targeted locus would retain regulation by 
the endogenous promoter. RF8 ES cells (129/SvJae origin) (52) were elec-
troporated with linearized vector, selected, and targeted ES clones were 
identifi  ed by genomic Southern analysis (see Supplemental Materials and 
methods). Two out of three targeted clones were transiently transfected with 
MC-Cre (provided by Shinya Yamanaka, Institute for Frontier Medical 
Sciences, Kyoto University, Kyoto, Japan) to delete the loxP-fl  anked NeoR 
cassette and subclones verifi  ed as described (see Supplemental Materials and 
methods). IL-7Rα+/449F founders were generated by standard procedures 
and backcrossed at least six generations with C57BL/6 mice. PCR geno-
typing was performed with primers A (5′ T  C  T  T  C  C  T  G  A  A  C  A  G  C  C  A  G  ), 
B (5′ T C  T  C  T  T  C  T  G  T  G  A  G  C  T  A  C  G  G  ), and C (5′ C C  C  T  G  A  A  C  C  T  G  A  A  A-
C  A  T  A  A  A  ) for 30 cycles each of 30 s at 94°C, 30 s at 60°C, and 1 min at 
72°C. Primers A and B amplify a 489-bp fragment from the WT allele, whereas 
primers A and C amplify a 595-bp fragment from the knock-in allele.JEM VOL. 204, March 19, 2007  629
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Antibodies. FITC, PE, CyC, APC, Alexa 647, APC Cy7, PE Cy7, and bio-
tinylated antibodies were obtained from BD Biosciences (anti-γδ TCR, 
NK1.1, B220, Gr-1, Mac-1, CD3ε, CD4, CD8α, CD25, CD44, CD69, 
CD90.1, CD90.2, c-kit, IL-2/15Rβ, γc, HSA, Sca-1, TCR-β, Bcl-2, phospho-
STAT5, BrdU, and H-2Kb–Ig recombinant fusion protein, and mouse 
DimerXI) or eBioscience (anti-CD4, CD8α, CD45.2, and IL-7Rα). Unlabeled 
antibodies were obtained from Cell Signaling Technology (anti-Akt, phospho-
Akt Ser473, phospho-STAT5, phospho-Erk, Erk, and p38 MAPK), BD 
Biosciences (anti-phospho p38 MAPK), Santa Cruz Biotechnology, Inc. 
(anti–IL-7Rα), and Sigma-Aldrich (anti–α-tubulin). Rabbit polyclonal anti-
STAT5A and STAT5B were a gift from Dr. Lothar Hennighausen (National 
Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of 
Health, Bethesda, MD). Fluorescent secondary antibodies used in the Odyssey 
Infrared Imaging System (LiCOR) were obtained from Rockland Immuno-
chemicals (goat anti–rabbit IgG IRDye800) and Invitrogen (goat anti–mouse 
IgG Alexa 680). Horseradish peroxidase–conjugated secondary antibodies 
used in chemiluminescent immunoblotting were from GE Healthcare.
Flow cytometry. Surface staining for stem cell and lymphocyte characteri-
zation was performed according to standard procedures. For analysis of 
  phospho-STAT5 activation, cells were acid stripped (10 mM Na citrate, 
pH 4, 140 mM NaCl) and starved for 4 h in serum-free RPMI + 1% BSA. 
Cells were stimulated by addition of 25 ng/ml recombinant murine IL-7 
(Chemicon) for 10 min at 37°C in serum-free media. Cells were fi  xed for 
10 min in 1% PFA at RT and permeabilized in 100% ice-cold methanol. 
Cells were then stained for detection of phospho-STAT5, CD4, and CD8. 
For detection of Bcl-2 up-regulation, cells were cytokine stripped and serum 
starved as described for phospho-STAT5, and stimulated with IL-7 for 20 h 
at 37°C. Cells were fi  xed and permeablized for 1 h at RT in 1% PFA, 0.1% 
Tween-20 and stained for surface markers and intracellular Bcl-2. Samples 
were collected on either a FACSCalibur or LSRII (BD Biosciences), and 
data were analyzed with FlowJo software (Tree Star).
Cell cycle analysis. Two doses of 1 mg BrdU were delivered i.p. to WT 
and IL-7Rα449F mice at 4-h intervals. 20 h after the second BrdU dose, 
thymi were harvested and stained for surface markers (for DN, α-CD25, 
CD44, and lineage cocktail α-CD3, CD4, CD8, γδ TCR, Gr-1, Mac1 
B220; for DP, α-CD4, CD8). Cells were then treated according to manu-
facturer’s instructions for detection of BrdU (BD Biosciences).
Western blotting. Samples were lysed in lysis buff  er (10 mM Tris-HCl, pH 
7.5, 5 mM EDTA, 1% Triton X-100), and cleared lysates were quantifi  ed 
and normalized for total protein level. For immunoblot analysis of IL-7Rα 
expression, total thymocyte lysates were resolved by SDS-PAGE, and pro-
teins were electrophoretically transferred to nitrocellulose. A polyclonal 
anti–IL-7Rα from Santa Cruz Biotechnology, Inc. (sc-662) was used for 
detection and visualized with donkey anti–rabbit HRP and SuperSignal 
West Pico ECL reagents (Pierce Chemical Co.). For analysis of signaling 
pathways, WT and IL-7Rα449F CD8 T cells were cultured for 48 h at 106 
cells/ml in the presence of 2 μg/ml ConA in complete media, then main-
tained in 20 U/ml IL-2 for 3 d, and fi  nally, cytokine stripped and serum 
starved for 4 h. Cells were stimulated with 25 ng/ml IL-7, 1 μg soluble 
α-CD3, or 10 nM IL-2. Western blots were probed for detection of phos-
phorylated and total levels of Akt, p38 MAPK, Erk, and STAT5 using the 
LiCor Odyssey imaging system.
Homeostatic proliferation. Spleens were collected from mice and pre-
pared as single cell suspensions. Red blood cells were lysed using ACK lysis 
buff  er (155 mM NH4Cl, 10 mM KHCO3, 100 μM EDTA). Lymphocytes 
were B cell depleted using sheep anti–mouse IgG DynaBeads (Invitrogen). 
Purifi  ed cells were CFSE labeled as previously described (53). T cell subsets 
were quantifi  ed by fl  ow cytometry, and 5 × 106 T cells were transferred i.v. 
to CD45.1 congenic mice that either had or had not received a sublethal 
dose of irradiation the previous day (600 rads). After 7 d, spleens of recipient 
mice were harvested and stained for CD45.2, CD4, and CD8α.
Competitive repopulation. Bone marrow cells were isolated from the fe-
murs of Thy1.1 and IL-7Rα449F mice. After red blood cell lysis, 2 × 106 
whole bone marrow cells from Thy1.1 (CD45.2+, CD90.1+) and 
IL-7Rα449F (CD45.2+, CD90.2+) donors were adoptively transferred into 
lethally irradiated (1200 rads) BoyJ (CD45.1+) congenic recipients. Recipi-
ent mice received Biosol (neomycin sulfate) at 2 mg/ml in their water the 
night before irradiation and for the next 2 wk. At 4 wk after injection, re-
cipient thymuses were harvested and stained for CD45.2, CD90.1, CD90.2, 
CD4, and CD8α.
In vitro TCR stimulation assay. Peripheral T cells were purifi  ed from 
the spleens of WT and IL-7Rα449F mice using α-CD4 and α-CD8 MACS 
beads (Miltenyi Biotec) according to manufacturer’s instructions. Puri-
fi  ed, CFSE-labeled CD4 and CD8 WT and IL-7Rα449F T cells were cul-
tured in vitro for 3 d in RPMI + 10% FBS in the presence of 1 μg 
α-CD28 and the indicated doses of plate-bound α-CD3. Cells were har-
vested, stained for CD4 and CD8, and dilution of CFSE was monitored 
by cytometry.
L. monocytogenes infection and response assays. Naive C57BL/6 and 
IL-7Rα449F mice were injected intravenously with 105 CFU or previously 
immunized mice infected with 106 CFU of rLM-SIY in PBS. At appropriate 
time points after infection, spleens were collected, homogenized to single 
cell suspension, red blood cells lysed, and the cells restimulated in vitro with 
epitope-specifi  c peptides for 5 h at 37°C in the presence of 1 μl/106 cells 
Golgi plug (BD Biosciences). The CD4-specifi  c LLO peptide was added at 
5 μM and the CD8-specifi  c SIY peptide at 1 μM in Iscove’s media + 10% 
FCS. After stimulation, cells were fi  xed and permeabilized in 2% PFA, 0.2% 
Tween-20 for 20 min at RT. Cells were then stained for CD4, CD8α, and 
IFN-γ. Antigen-specifi  c cells were designated as CD4+ or CD8+ cells that 
expressed IFN-γ after in vitro challenge with antigenic peptides. SIY pep-
tide loading of the BD Biosciences MHC I–Ig dimer fusion protein was per-
formed according to manufacturer’s instructions with a 40-M excess of 
peptide. For fl  ow cytometric analysis of SIY-specifi  c CD8 T cells using pep-
tide loaded dimer, 0.5 μg dimer/2 × 106 cells was used.
For adoptive transfer experiments, WT T cells were purifi  ed  from 
Thy1.1 mice by B cell depletion, and 107 T cells were injected intravenously 
into C57BL/6 or IL-7Rα449F recipients. The next day, recipient mice were 
infected with 105 CFU of rLM-SIY, and analysis was performed as outlined 
in the previous paragraph (with addition of anti-CD90.1) at 7 d after infection. 
Analysis of Bcl-2 levels and BrdU incorporation was performed with or with-
out peptide stimulation and without IL-7 stimulation. Bcl-2 intracellular 
staining was performed as described previously. For cell cycle analysis, mice 
were given a single 2-mg dose of BrdU i.p. and then fed BrdU in their water 
for 8 d (0.8 mg/ml). Staining was performed according to manufacturer’s 
instructions (BD Sciences).
Statistical analysis. All data are presented as mean ± SEM and analyzed by 
Student’s t test. Signifi  cance was set at p-value of <0.05.
Online supplemental material. Fig. S1 shows genomic Southern blot 
analysis of ES clones with knock-in targeted IL-7Rα loci. Fig. S2 shows that 
IL-7Rα449F peripheral T cells have largely unperturbed γc and IL-2/15Rβ 
receptor subunits. Supplemental Materials and methods provides details of 
the knock-in targeting of the IL-7Rα locus. Online supplemental material 
available at http://www.jem.org/cgi/content/org/jem.20061871/DC1.
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